Childhood acute lymphoblastic leukemia

Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy

H. F. Tao, Liu, Y. S., Fang, J. L., Su, Y. Z., Chen, F. H., Zhou, L. Y., and Zhu, Y. S., Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy, vol. 13, pp. 2020-2031, 2014.

This study explored the clinical significance of silencer of death domain (SODD) expression in childhood acute lymphoblastic leukemia (ALL) and its influence on chemotherapy as well as the effect of SODD expression on apoptosis of leukemic cells. The expression of SODD proteins in different ALL groups was determined by immunocytochemistry. The SODD RNAi-interfering plasmid was constructed and transferred to Jurkat cells, and the effects of SODD expression on cell proliferation and apoptosis were analyzed using the MTT and FCM methods.

XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia

J. P. Meza-Espinoza, Peralta-Leal, V., Gutierrez-Angulo, M., Macias-Gomez, N., Ayala-Madrigal, M. L., Barros-Nuñez, P., Duran-Gonzalez, J., and Leal-Ugarte, E., XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia, vol. 8, pp. 1451-1458, 2009.

We examined the influence of the Arg194Trp, Arg280His, and Arg399Gln polymorphisms of XRCC1 (X-ray repair cross-complementing group 1) on the development of childhood acute lymphoblastic leukemia (ALL) in 120 ALL patients and 120 controls in Mexico. All of them were genotyped for these polymorphisms, using polymerase chain reaction. No significant differences in allele and genotype frequencies for any polymorphism were observed between patients and controls.

Subscribe to Childhood acute lymphoblastic leukemia